The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer
Abstract Loss of PTEN expression, via homozygous or hemizygous deletion, is common in PIK3CA mutant ER + BC tumors. We assessed reduction of PTEN protein expression on AKT inhibitor capivasertib efficacy in PIK3CA altered tumors. In PIK3CA altered, PTEN protein high models, PI3Kα and AKT inhibition...
Saved in:
| Main Authors: | Valentina Cutano, Ming Li Chia, Eleanor M. Wigmore, Lorna Hopcroft, Stuart C. Williamson, Amanda L. Christie, Brandon Willis, James Kerr, Jenny Ashforth, Rhys Fox, Sophie D’Arcy, Lauren Bradshaw, Catherine Blaker, Cath Eberlein, Lambert Montava-Garriga, Elza C. de Bruin, Susan E. Critchlow, Kevin M. Brindle, Simon T. Barry, Susana Ros |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | npj Breast Cancer |
| Online Access: | https://doi.org/10.1038/s41523-025-00752-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
P479: PIK3CA-related overgrowth syndrome: To exome or not?
by: Moon Ley Tung, et al.
Published: (2025-01-01) -
Oncogenic PIK3CA corrupts growth factor signaling specificity
by: Ralitsa R Madsen, et al.
Published: (2024-12-01) -
Dysfunctional mechanotransduction regulates the progression of PIK3CA-driven vascular malformations
by: Wen Yih Aw, et al.
Published: (2025-03-01) -
Mutations of the PIK3CA gene in patients with breast cancer in the Krasnoyarsk region
by: A. V. Zyuzyukina, et al.
Published: (2024-07-01) -
Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancer
by: Gizem Teoman, et al.
Published: (2024-12-01)